Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    8652811 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Study of Bendamustine, Lenalidomide and Low-dose Dexamethasone, for the Treatment of Patients With Relapsed Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Bendamustine;   Drug: Lenalidomide;   Drug: Dexamethasone
2 Completed
Has Results
Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia
Conditions: Leukemia;   Lymphocytic;   Chronic
Intervention: Drug: LMB-2
3 Completed A Phase I Trial of Autologous CLL B Cells Transduced to Express Chimeric CD154 (ISF35)
Condition: Chronic Lymphocytic Leukemia
Intervention: Biological: ISF35
4 Completed A Phase I Extension Trial of Repeated Infusions of ISF35
Condition: Chronic Lymphocytic Leukemia
Intervention: Biological: ISF35

Indicates status has not been verified in more than two years